)
Poly Medicure (531768) investor relations material
Poly Medicure Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Closed acquisitions of Citieffe Group (Italy, orthopedics) and PendraCare Group (Netherlands, cardiology), expanding the global footprint and addressable market by $70 billion.
Launched Poly Medic/Polymed Academy of Clinical Excellence and expanded AI-powered training programs.
Board approved unaudited standalone and consolidated financial results for Q2 and H1 ended 30th September 2025, with financials reviewed and unmodified by auditors.
Domestic business saw strong growth, while international business is recovering, especially in Europe and ROW markets.
Launched 8 new products in Q2 FY26 and initiated clinical studies for RisoR stent in India and Europe.
Financial highlights
Q2 FY26 consolidated revenue: INR 444 crore (₹44,388.16 lacs), up 5.7% YoY and 10.1% QoQ; H1 FY26 revenue: INR 847 crore (₹92,315.46 lacs), up 5.3% YoY.
Q2 gross profit: INR 308 crore, gross margin 69.4%; operating EBITDA: INR 119 crore, margin 26.8% (excluding INR 3.2 crore one-time acquisition cost).
Q2 net profit: INR 92 crore (₹9,183.50 lacs), net margin 19.2%; H1 net profit: INR 185 crore (₹18,491.76 lacs), up 14.5% YoY, net margin 20%.
H1 operating EBITDA: INR 226 crore, margin 26.7%; PAT up 14.5% YoY.
Basic EPS for Q2 FY26 was ₹9.17, up 0.6% YoY.
Outlook and guidance
FY26 revenue growth guidance revised to 15%-16% (from 20% earlier); H2 revenue guidance: INR 1,080-1,090 crore (25% increase over H1).
Domestic business expected to grow 28%-30% in FY26; international business guided for ~10% growth including acquisitions.
Operating EBITDA margin guidance maintained at 25%-27%, with H1 tracking near the higher end.
CapEx for FY26: INR 250 crore; similar CapEx expected in FY27.
Management expects to finalize fair value measurements for the Pendra Care Group acquisition within one year from acquisition date.
Next Poly Medicure earnings date
Next Poly Medicure earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage